Patents by Inventor David RHAINDS

David RHAINDS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Co-culture system and method for in vitro assessment of reverse cholesterol transport
    Patent number: 11840707
    Abstract: The present invention provides a co-culture system and method for assessing cellular cholesterol (Choi) efflux and uptake in vitro. The co-culture system mimics in vivo Choi efflux and uptake in the context of mammalian physiology. The methods and systems provided can be used in some embodiments to evaluate the effect of a pharmacological agent on cellular Choi efflux and uptake or for diagnostic purposes.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: December 12, 2023
    Assignee: INSTITUT DE CARDIOLOGIE DE MONTREAL
    Inventors: David Rhainds, Éric Rhéaume, David Busseuil, Jean-Claude Tardif
  • A CO-CULTURE SYSTEM AND METHOD FOR IN VITRO ASSESSMENT OF REVERSE CHOLESTEROL TRANSPORT
    Publication number: 20190284527
    Abstract: The present invention provides a co-culture system and method for assessing cellular cholesterol (Choi) efflux and uptake in vitro. The co-culture system mimics in vivo Choi efflux and uptake in the context of mammalian physiology. The methods and systems provided can be used in some embodiments to evaluate the effect of a pharmacological agent on cellular Choi efflux and uptake or for diagnostic purposes.
    Type: Application
    Filed: May 30, 2017
    Publication date: September 19, 2019
    Inventors: David RHAINDS, Éric RHÉAUME, David BUSSEUIL, Jean-Claude TARDIF